STRATA Net Debt from 2010 to 2025

SSKN Stock

USD 2.64 0.03 1.12%

STRATA Skin Net Debt yearly trend continues to be very stable with very little volatility. Net Debt is likely to grow to about 10.7 M this year. Net Debt is the total debt of STRATA Skin Sciences minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2004-12-31

Previous Quarter

11 M

Current Value

9.4 M

Quarterly Volatility

13.7 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check STRATA Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among STRATA Skin's main balance sheet or income statement drivers, such as Total Revenue of 19.5 M, Gross Profit of 11.1 M or Other Operating Expenses of 47.9 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0 or PTB Ratio of 1.43. STRATA financial statements analysis is a perfect complement when working with STRATA Skin Valuation or Volatility modules.

Check out the analysis of STRATA Skin Correlation against competitors.

Latest STRATA Skin's Net Debt Growth Pattern

Below is the plot of the Net Debt of STRATA Skin Sciences over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. STRATA Skin's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in STRATA Skin's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

STRATA Net Debt Regression Statistics

	Arithmetic Mean	533,508
	Geometric Mean	5,126,236
	Coefficient Of Variation	2,244
	Mean Deviation	9,174,371
	Median	278,000
	Standard Deviation	11,972,241
	Sample Variance	143.3T
	Range	47.9M
	R-Value	0.42
	Mean Square Error	126T
	R-Squared	0.18
	Significance	0.10
	Slope	1,065,263
	Total Sum of Squares	2150T

STRATA Net Debt History

	2025	10.7 M
	2024	10.2 M
	2023	8.8 M
	2022	3 M
	2021	-4.6 M
	2020	278 K

Other Fundumenentals of STRATA Skin Sciences

Net Debt To E B I T D A

STRATA Skin Net Debt component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Current Assets	Total Liab	Net Debt	Current Deferred Revenue	Accounts Payable	Net Receivables	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Long Term Debt	Good Will	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.68	-0.8	0.52	0.71	0.3	0.63	0.7	0.9	0.17	0.85	0.22	0.69	-0.6	0.48	0.9	0.8	0.27	0.09	0.37	-0.02	0.36	0.4
Total Stockholder Equity	0.68		-0.56	0.84	0.11	-0.38	0.49	0.31	0.36	0.22	0.38	0.31	0.17	-0.09	-0.09	0.52	0.39	0.14	-0.15	-0.05	0.38	0.57	0.09
Retained Earnings	-0.8	-0.56		-0.38	-0.65	-0.37	-0.54	-0.61	-0.75	-0.19	-0.66	-0.31	-0.64	0.75	-0.49	-0.75	-0.84	-0.34	0.01	-0.19	0.13	-0.24	-0.39
Total Current Assets	0.52	0.84	-0.38		0.04	-0.52	0.51	0.01	0.22	0.24	0.07	0.44	-0.12	0.19	-0.16	0.26	0.27	-0.08	-0.38	-0.01	0.19	0.47	0.27
Total Liab	0.71	0.11	-0.65	0.04		0.78	0.49	0.63	0.87	-0.01	0.76	0.06	0.71	-0.75	0.86	0.77	0.77	0.25	0.14	0.46	-0.52	0.03	0.64
Net Debt	0.3	-0.38	-0.37	-0.52	0.78		0.03	0.54	0.58	0.04	0.57	-0.28	0.68	-0.8	0.82	0.52	0.51	0.32	0.45	0.34	-0.44	-0.26	0.3
Current Deferred Revenue	0.63	0.49	-0.54	0.51	0.49	0.03		0.21	0.65	0.1	0.46	0.55	0.17	-0.13	0.1	0.63	0.68	0.18	-0.58	0.13	-0.14	0.52	0.65
Accounts Payable	0.7	0.31	-0.61	0.01	0.63	0.54	0.21		0.72	0.0	0.76	-0.09	0.77	-0.72	0.62	0.74	0.62	0.06	0.47	0.29	0.08	0.41	0.05
Net Receivables	0.9	0.36	-0.75	0.22	0.87	0.58	0.65	0.72		0.03	0.86	0.17	0.72	-0.67	0.66	0.91	0.9	0.36	0.03	0.36	-0.3	0.24	0.6
Short Term Debt	0.17	0.22	-0.19	0.24	-0.01	0.04	0.1	0.0	0.03		0.01	0.04	0.08	-0.06	-0.21	0.22	0.16	0.27	-0.05	0.0	0.3	0.02	-0.04
Intangible Assets	0.85	0.38	-0.66	0.07	0.76	0.57	0.46	0.76	0.86	0.01		-0.07	0.76	-0.74	0.59	0.9	0.72	0.34	0.33	0.36	-0.05	0.21	0.23
Common Stock	0.22	0.31	-0.31	0.44	0.06	-0.28	0.55	-0.09	0.17	0.04	-0.07		0.02	0.11	-0.19	0.04	0.24	-0.07	-0.54	0.03	-0.18	0.22	0.46
Property Plant Equipment	0.69	0.17	-0.64	-0.12	0.71	0.68	0.17	0.77	0.72	0.08	0.76	0.02		-0.88	0.68	0.69	0.56	0.28	0.5	0.55	-0.16	-0.06	0.18
Net Tangible Assets	-0.6	-0.09	0.75	0.19	-0.75	-0.8	-0.13	-0.72	-0.67	-0.06	-0.74	0.11	-0.88		-0.77	-0.69	-0.65	-0.34	-0.52	-0.36	0.19	0.06	-0.17
Long Term Debt	0.48	-0.09	-0.49	-0.16	0.86	0.82	0.1	0.62	0.66	-0.21	0.59	-0.19	0.68	-0.77		0.55	0.54	0.26	0.47	0.28	-0.52	-0.1	0.39
Good Will	0.9	0.52	-0.75	0.26	0.77	0.52	0.63	0.74	0.91	0.22	0.9	0.04	0.69	-0.69	0.55		0.87	0.41	0.13	0.26	0.01	0.4	0.39
Capital Surpluse	0.8	0.39	-0.84	0.27	0.77	0.51	0.68	0.62	0.9	0.16	0.72	0.24	0.56	-0.65	0.54	0.87		0.38	-0.14	0.17	-0.25	0.31	0.64
Deferred Long Term Liab	0.27	0.14	-0.34	-0.08	0.25	0.32	0.18	0.06	0.36	0.27	0.34	-0.07	0.28	-0.34	0.26	0.41	0.38		0.02	-0.39	-0.21	-0.15	0.26
Long Term Debt Total	0.09	-0.15	0.01	-0.38	0.14	0.45	-0.58	0.47	0.03	-0.05	0.33	-0.54	0.5	-0.52	0.47	0.13	-0.14	0.02		0.14	0.26	-0.14	-0.55
Short Long Term Debt	0.37	-0.05	-0.19	-0.01	0.46	0.34	0.13	0.29	0.36	0.0	0.36	0.03	0.55	-0.36	0.28	0.26	0.17	-0.39	0.14		-0.21	-0.28	0.19
Net Invested Capital	-0.02	0.38	0.13	0.19	-0.52	-0.44	-0.14	0.08	-0.3	0.3	-0.05	-0.18	-0.16	0.19	-0.52	0.01	-0.25	-0.21	0.26	-0.21		0.54	-0.72
Net Working Capital	0.36	0.57	-0.24	0.47	0.03	-0.26	0.52	0.41	0.24	0.02	0.21	0.22	-0.06	0.06	-0.1	0.4	0.31	-0.15	-0.14	-0.28	0.54		-0.02
Capital Stock	0.4	0.09	-0.39	0.27	0.64	0.3	0.65	0.05	0.6	-0.04	0.23	0.46	0.18	-0.17	0.39	0.39	0.64	0.26	-0.55	0.19	-0.72	-0.02

Click cells to compare fundamentals

About STRATA Skin Financial Statements

STRATA Skin investors utilize fundamental indicators, such as Net Debt, to predict how STRATA Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	10.2 M	10.7 M
Net Debt To EBITDA	(3.01)	(2.86)

When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:

How To Invest In STRATA

Details

Is STRATA Stock a good investment?

Details

What is STRATA Skin's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of STRATA Skin Correlation against competitors.

You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.60)

Revenue Per Share

8.978

Quarterly Revenue Growth

(0.01)

Return On Assets

(0.09)

Return On Equity

(0.73)

The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

STRATA Net Debt from 2010 to 2025

Latest STRATA Skin's Net Debt Growth Pattern

STRATA Net Debt Regression Statistics

STRATA Net Debt History

Other Fundumenentals of STRATA Skin Sciences

STRATA Skin Net Debt component correlations

About STRATA Skin Financial Statements

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY